Article successfully added.

CyFlow™ CD11c Purified

CyFlow™ CD11c Purified
Alternative Name: p150
Antibody: Yes
Antigen: CD11c
Application: Flow cytometry, Immunohistochemistry (frozen sections), Immunoprecipitation
Clonality: monoclonal
Clone: BU15
Field of Interest: Immunophenotyping
Format/Fluorochrome: Purified
Isotype: IgG1
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human, Non-Human Primates
Product number: CF757356

For Research Use Only

$141.30 CAD*

Price excludes any applicable taxes plus shipping costs

HLDA Workshop HLDA III—WS Code M 256 HLDA V—WS Code AS S143 HLDA VI—WS Code AS Ref.6... more
CyFlow™ CD11c Purified
HLDA WorkshopHLDA III—WS Code M 256 HLDA V—WS Code AS S143 HLDA VI—WS Code AS Ref.6
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenDendritic cells of synovial fluid
Background InformationCD11c (αX integrin subunit) forms complex with CD18 (β2 integrin subunit) and is expressed mainly on tissue macrophages and dendritic cells. CD11c binds to complement fragment iC3b, fibrinogen, VCAM-1 and ICAM-2 or e.g. CD90. Like other β2 integrins, CD11c/CD18 plays roles in cell migration and phagocytosis. Moreover, interaction of CD11c/CD18 with plasminogen regulates plasmin activities, and interaction with heparin counteracts binding of iC3b.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Hogg N, Takacs L, Palmer DG, Selvendran Y, Allen C: The p150,95 molecule is a marker of human mononuclear phagocytes: comparison with expression of class II molecules. Eur J Immunol. 1986 Mar; 16(3):240‑8. < PMID: 3456894 > | McMichael AJ, Beverley PCL, Cobbold S, et al (Eds): Leucocyte Typing III, White Cell Differentiation Antigens. Oxford University Press, Oxford. 1987; 1‑1050. < NLM ID: 8913266 > | Doussis IA, Gatter KC, Mason DY: CD68 reactivity of non‑macrophage derived tumours in cytological specimens. J Clin Pathol. 1993 Apr; 46(4):334‑6. < PMID: 7684403 > | Trowald-Wigh G, Johannisson A, Håkansson L: Canine neutrophil adhesion proteins and Fc‑receptors in healthy dogs and dogs with adhesion protein deficiency, as studied by flow cytometry. Vet Immunol Immunopathol. 1993 Oct; 38(3‑4):297‑310. < PMID: 8291207 > | Van der Vieren M, Le Trong H, Wood CL, Moore PF, St John T, Staunton DE, Gallatin WM: A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM‑3. Immunity. 1995 Dec; 3(6):683‑90. < PMID: 8777714 > | Kishimoto T, Goyert S, Kikutani H, Mason D, Miyasaka M, Moretta L, Ohno T, Okumura K, Shaw S, Springer TA, Sugamura K, Sugawara H, von dem Borne AEGK, Zola H (Eds): Leucocyte Typing VI. Garland Publishing Inc, New York. 1997; 1‑1342. < NLM ID: 9712219 > | Rezzonico R, Imbert V, Chicheportiche R, Dayer JM: Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP‑1alpha) and MIP‑1beta production in primary human monocytes through a pathway dependent on nuclear factor‑kappaB. Blood. 2001 May 15; 97(10):2932‑40. < PMID: 11342414 > | Myou S, Zhu X, Boetticher E, Qin Y, Myo S, Meliton A, Lambertino A, Munoz NM, Hamann KJ, Leff AR: Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2‑integrin caused by ERK‑independent activation of cPLA2. Immunology. 2002 Sep; 107(1):77‑85. < PMID: 12225365 > | Bullard DC, Hu X, Adams JE, Schoeb TR, Barnum SR: p150/95 (CD11c/CD18 expression is required for the development of experimental autoimmune encephalomyelitis. Am J Pathol. 2007 Jun; 170(6):2001‑8. < PMID: 17525267 > | Sadhu C, Ting HJ, Lipsky B, Hensley K, Garcia-Martinez LF, Simon SI, Staunton DE: CD11c/CD18: novel ligands and a role in delayed‑type hypersensitivity. J Leukoc Biol. 2007 Jun; 81(6):1395‑403. < PMID: 17389580 > | Vorup-Jensen T, Chi L, Gjelstrup LC, Jensen UB, Jewett CA, Xie C, Shimaoka M, Linhardt RJ, Springer TA: Binding between the integrin alphaXbeta2 (CD11c/CD18 and heparin. J Biol Chem. 2007 Oct 19; 282(42):30869‑77. < PMID: 17699512 > | Gang J, Choi J, Lee JH, Nham SU: Identification of critical residues for plasminogen binding by the alphaXI‑domain of the beta2 integrin, alphaXbeta2. Mol Cells. 2007 Oct 31; 24(2):240‑6. < PMID: 17978577 > | Angel CE, Lala A, Chen CJ, Edgar SG, Ostrovsky LL, Dunbar PR: CD14+ antigen‑presenting cells in human dermis are less mature than their CD1a+ counterparts. Int Immunol. 2007 Nov; 19(11):1271‑9. < PMID: 17804688 > | Sadhu C, Hendrickson L, Dick KO, Potter TG, Staunton DE: Novel Tools for Functional Analysis of CD11c: Activation‑Specific, Activation‑Independent, and Activating Antibodies. J Immunoassay Immunochem. 2008; 29(1):42‑57. < PMID: 18080879 >